(Q40842721)

24 September 2017

Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy (English)

1 reference

24 September 2017

Toshiyuki Yano

1

1 reference

24 September 2017

Shinya Shimoshige

2

1 reference

24 September 2017

Takayuki Miki

3

1 reference

24 September 2017

Masaya Tanno

4

1 reference

24 September 2017

Atsushi Mochizuki

5

1 reference

24 September 2017

Takefumi Fujito

6

1 reference

24 September 2017

Satoshi Yuda

7

1 reference

24 September 2017

Atsuko Muranaka

8

1 reference

24 September 2017

Makoto Ogasawara

9

1 reference

24 September 2017

Akiyoshi Hashimoto

10

1 reference

24 September 2017

Kazufumi Tsuchihashi

11

1 reference

24 September 2017

Tetsuji Miura

12

1 reference

24 September 2017

28 December 2015

1 reference

Journal of Molecular and Cellular Cardiology

24 September 2017

1 reference

24 September 2017

91

1 reference

24 September 2017

6-9

1 reference

mTORC1- and mTORC2-interacting proteins keep their multifunctional partners focused.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Everolimus-responsive dilated cardiomyopathy in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Altered signaling for mitochondrial and myofibrillar biogenesis in skeletal muscles of patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Metabolomic analysis of pressure-overloaded and infarcted mouse hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Akt and mTOR mediate programmed necrosis in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

Heparin-binding EGF-like growth factor induces heart interstitial fibrosis via an Akt/mTor/p70s6k pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2015.12.022

10.1016/J.YJMCC.2015.12.022

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference